Share on: 
Community College Hire
Website: Kite

Kite, a Gilead company, produces personalized cell therapies for treating cancer. These include YescartaⓇ, which was approved by the FDA in 2021 and TecartusⓇ, the first approved chimeric antigen receptor (CAR) T cell therapy for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). 

Internship Page(s): 
Kite Pharma, Inc.
Santa Monica CA
United States
Frederick MD
United States